CD4 and neoplasm: To comprehensively elucidate the trends in Th1/Th17 cell differentiation in the context of tumour metabolic competition and the association between metabolic reprogramming and epigenetic marker expression in specific CD4+ T‐cell subtypes, further investigations, particularly single‐cell multiomics analyses, are needed.